VIRSIK PETER (Chief Operating Officer) sold 18.5% of their position (2.08K shares) of ESSA PHARMA INC. on the open market
Open‑market sale worth $12.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/3/2024ACC: 0000950170-24-103055
Officer· Chief Operating Officer
Since Oct 2020
-2.08K
Net shares
Net seller
$12.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.08K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−2.08K
Price / share
$6.03
Trade value
$12.55K
% of position
18.5%
9/3/2024
11.25K→9.16K
Total
Net shares
−2.08K
Net value
-$12.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/3/2024 | S · Sale | −2.08K | $6.03 | $12.55K | 18.5% | 11.25K | 9.16K |
| Total | −2.08K | -$12.55K | ||||||
Derivative Transactions0
No derivative transactions reported